atrinpharma.com

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.atrinpharma.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change

Meta Tags

Title	HOME \|
Description	Atrin Atrin’s DNA Damage Response development pipeline is based on products resulting from a rationally designed series of novel conformationally restricted macrocyclic molecules, which have the highest known potency for inhibiting ATR, and exhibit
Keywords	ATR, Cancer, DDR, DNA, Damage

Server Information

WebSite	atrinpharma.com
Host IP	23.236.62.147
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

atrinpharma.com Valuation

US$3,551,852

Last updated: 2023-05-17 08:50:16

atrinpharma.com has Semrush global rank of 2,979,940. atrinpharma.com has an estimated worth of US$ 3,551,852, based on its estimated Ads revenue. atrinpharma.com receives approximately 409,829 unique visitors each day. Its web server is located in United States, with IP address 23.236.62.147. According to SiteAdvisor, atrinpharma.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$3,551,852
Daily Ads Revenue	US$3,279
Monthly Ads Revenue	US$98,359
Yearly Ads Revenue	US$1,180,308
Daily Unique Visitors	27,322
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
atrinpharma.com.	A	3600	IP: 23.236.62.147
atrinpharma.com.	NS	3600	NS Record: dns2.site5.com.
atrinpharma.com.	NS	3600	NS Record: dns.site5.com.
atrinpharma.com.	MX	3600	MX Record: 10 mx1.emailsrvr.com.
atrinpharma.com.	MX	3600	MX Record: 20 mx2.emailsrvr.com.
atrinpharma.com.	TXT	600	TXT Record: v=spf1 include:emailsrvr.com ~all
atrinpharma.com.	TXT	600	TXT Record: v=spf1+a+mx+include:websitewelcome.com~all

HtmlToTextCheckTime:2023-05-17 08:50:16

top of page HOME HOME 2023 LEADERSHIP BOARD OF DIRECTORS SCIENTIFIC ADVISORY BOARD TARGETING DDR TECHNOLOGY PIPELINE PUBLICATIONS CONTACT US Atrin Pharmaceuticals Atrin Pharmaceuticals is a private biopharmaceutical company pioneering the discovery & development of proprietary molecules targeting DNA Damage and Response (DDR) pathways to treat a broad spectrum of cancers associated with synthetic lethality and the deregulated DNA Damage Response. The concept of synthetic lethality is that cells can tolerate the loss of function of a single gene/protein as a stand alone but not in combination with the loss of function of another gene/protein. When one pathway is functionally lost in cancer, it increased the reliance on another gene/protein to maintain viability. Atrin is targeting the DDR pathway to develop new medicines to treat patients with a broad spectrum of cancers through selective synthetic lethal interactions. Atrin’s scientific founders were the first to discover the key role

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Tue, 15 Mar 2022 09:36:18 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.atrinpharma.com/
strict-transport-security: max-age=3600
Age: 51742
Server-Timing: cache;desc=hit, varnish;desc=hit, dc;desc=42
X-Seen-By: gv/XVF9HsGpk8A2KWukUzOwfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVho24eAEbfscWhcpKw1HIzZ,m0j2EEknGIVUW/liY8BLLlE5ByQns6DUljTJazv+2SdGkFvVdT2Nq6f3Hedj7ewB,2d58ifebGbosy5xc+FRaluOZol6O3rhE+/jx8F+9NusardFiCRMM+pY76tB7CUVslcwU+T1XMC44FSIlUCxN0w==,2UNV7KOq4oGjA5+PKsX47Cbe/tT3rmjvdOcTIXYlFyYfbJaKSXYQ/lskq2jK6SGP
Cache-Control: no-cache
X-Wix-Request-Id: 1647336978.54270840739496995
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Tue, 15 Mar 2022 09:36:18 GMT
content-type: text/html; charset=UTF-8
content-length: 304370
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
etag: W/"b12d832fe1975de0f50f50afc216a5c6"
content-language: en
strict-transport-security: max-age=3600
age: 8743
set-cookie: ssr-caching=cache#desc=hit#varnish=hit#dc#desc=euw3; Max-Age=20; Expires=Tue, 15 Mar 2022 07:10:55 GMT
server-timing: cache;desc=hit, varnish;desc=hit, dc;desc=euw3
x-seen-by: sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkViAKrsOb4tJki127pPPGLM6,qquldgcFrj2n046g4RNSVCA9lUGGSSQQI3tXitet/XU=,2d58ifebGbosy5xc+FRaliPi5E9e+7hjXB4I9boaSLYKNd8R/0KhCmLl9DWLh8YvxmHv8JmZfQswK4rISLAEpMXg9hs7dc1D9n+1x6DEHXY=,2UNV7KOq4oGjA5+PKsX47Ap6L/PfruwthWYF2FkPoC1YgeUJqUXtid+86vZww+nL
cache-control: no-cache
vary: Accept-Encoding,Accept-Encoding
accept-ranges: bytes
x-wix-request-id: 1647336978.861102358888123160
x-content-type-options: nosniff
server: Pepyaka/1.19.10

atrinpharma.com Whois Information

Domain Name: ATRINPHARMA.COM
Registry Domain ID: 1679216493_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.enom.com
Registrar URL: http://www.enomdomains.com
Updated Date: 2021-09-12T07:17:53Z
Creation Date: 2011-09-27T12:38:39Z
Registry Expiry Date: 2023-09-27T12:38:39Z
Registrar: eNom, LLC
Registrar IANA ID: 48
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: DNS.SITE5.COM
Name Server: DNS2.SITE5.COM
DNSSEC: unsigned
>>> Last update of whois database: 2022-03-15T10:09:26Z <<<

atrinpharma.com valuation and analysis